Beginning Cash: The amount of cash reported by the company on its previous statement.
CERo Therapeutics Holdings, Inc. (CERO) had Beginning Cash of $1.66M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-29.46M |
|
-- |
|
-- |
|
$3.85M |
|
$-3.85M |
|
$2.82M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-3.85M |
|
$-2.96M |
|
42.17M |
|
42.17M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$1.55M |
|
$0.13M |
|
$0.35M |
|
$1.90M |
|
$32.41M |
|
-- |
|
-- |
|
$32.41M |
|
$-31.79M |
|
$-30.51M |
|
$-30.51M |
|
63.81M |
|
| Cash Flow Statement Financials | |
$-5.09M |
|
-- |
|
$4.36M |
|
|
Beginning Cash |
$1.66M |
$0.94M |
|
$-0.72M |
|
$2.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3.24% |
|
3.37% |
|
-54.15% |
|
3.37% |
|
$-0.48 |
|
$-0.12 |
|
$-0.12 |
|